What if your immune system could fight cancer? Now it can with a cancer treatment created by Penn Medicine called CAR T cell therapy. CAR T is a form of immunotherapy that reprograms your body's own immune cells to seek and destroy every last cancer cell.

CAR T CELL THERAPY FOR LEUKEMIA

In a landmark decision, the FDA approved Penn's CAR T cell therapy for people up to the age of 25 years old with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL).

It is the first-ever gene therapy in the world available on the market and begins a new era of cancer treatment.

Learn more about immunotherapy at Penn: [ Ссылка ]

If you are interested in or have questions about CAR T therapy, please call 215-316-5127 or fill out our contact form: [ Ссылка ]

CAR T CELL THERAPY FOR OTHER CANCERS

Our success in CAR T cell therapy does not stop with leukemia. We are also testing a similar therapy to treat non-Hodgkin’s lymphoma and have a request for FDA approval underway.

There are a number of CAR T clinical trials available at Penn Medicine for all different forms of cancer. Many of our clinical trials aren't available anywhere else.

View available clinical trials: [ Ссылка ]
Learn about clinical trials by watching the video "What Is a Clinical Trial?": [ Ссылка ]
Request an appointment: [ Ссылка ]

свернуть